MARAVAI LIFESCIENCES HOLDINGS, INC.
Canonical company identity and public leadership record.
- Source reported. 31 claims from 3 sources.
- Not claimed by the company.
- Eval: not assessed.
- CEO
- Bernd Brust
- Chair
- R. Andrew Eckert
- Board
- 6 directorsAlpha calculation. Published seats
- Committees
- 3
- Evidence
- 3 sources31 published claims
- Open conflicts
- 0None open
Leadership
8 claims| Person | Role | Since | Status | Evidence |
|---|---|---|---|---|
| Bernd Brust | Chief Executive Officer | Not captured | Unknown | Source reportedE2 |
| Christine Dolan | Executive Vice President and General Manager, Cygnus Technologies | Not captured | Unknown | Source reportedE2 |
| Kevin Herde | Chief Financial Officer | Not captured | Unknown | Source reportedE4 |
| Kurt Oreshack | Executive Vice President, General Counsel and Secretary | Not captured | Unknown | Source reportedE2 |
| Peter Leddy | Chief Administrative Officer | Not captured | Unknown | Source reportedE5 |
| Raj Asarpota | Chief Financial Officer | Not captured | Unknown | Source reportedE2 |
| Rebecca Buzzeo | Executive Vice President and Chief Commercial Officer | Not captured | Unknown | Source reportedE6 |
| William E. Martin, III | Chief Executive Officer | Not captured | Unknown | Source reportedE7 |
Board
9 claims| Director | Status | Since | Committees | Evidence |
|---|---|---|---|---|
| Constantine Mihas | Independence not published | Compensation and Leadership Development Committee | Source reportedE3 | |
| Gregory T. Lucier | Independence not published | Nominating, Governance and Risk Committee | Source reportedE3 | |
| John DeFord | Independence not published | AUDIT COMMITTEE; Compensation and Leadership Development Committee, chair | Source reportedE3 | |
| Luke Marker | Independence not published | None published | Source reportedE3 | |
| Sean Cunningham | Independence not published | Nominating, Governance and Risk Committee | Source reportedE3 | |
| Susannah Gray | Independence not published | AUDIT COMMITTEE, chair; Compensation and Leadership Development Committee | Source reportedE3 | |
| Bernd Brust | Not independent | Not published | None published | Source reportedE2 |
| John DeFord, Ph.D. | Independent | Not published | None published | Source reportedE2 |
| R. Andrew Eckert | Independent; Chair | Not published | None published | Source reportedE2 |
Committees
10 claims| Committee | Chair | Members | Risks assigned | Evidence |
|---|---|---|---|---|
| AUDIT COMMITTEE | Susannah Gray | Susannah Gray, John DeFord | Not described in the published record | Source reportedE8 |
| Compensation and Leadership Development Committee | John DeFord | John DeFord, Constantine Mihas, Susannah Gray | Not described in the published record | Source reportedE8 |
| Nominating, Governance and Risk Committee | Not published | Gregory T. Lucier, Sean Cunningham | Not described in the published record | Source reportedE8 |
| Fact | Stated value | Evidence |
|---|---|---|
| Committee appointment | Susannah Gray: chair, AUDIT COMMITTEE | Source reportedE8 |
| Committee appointment | John DeFord: member, AUDIT COMMITTEE | Source reportedE8 |
| Committee appointment | John DeFord: chair, Compensation and Leadership Development Committee | Source reportedE8 |
| Committee appointment | Constantine Mihas: member, Compensation and Leadership Development Committee | Source reportedE8 |
| Committee appointment | Susannah Gray: member, Compensation and Leadership Development Committee | Source reportedE8 |
| Committee appointment | Gregory T. Lucier: member, Nominating, Governance and Risk Committee | Source reportedE8 |
| Committee appointment | Sean Cunningham: member, Nominating, Governance and Risk Committee | Source reportedE8 |
Financial context
1 claim| Fact | Stated value | Evidence |
|---|---|---|
| Security listing | MRVI (NASDAQ) | Source reportedE1 |
Other published claims
3 claims| Fact | Stated value | Evidence |
|---|---|---|
| Legal name | MARAVAI LIFESCIENCES HOLDINGS, INC. | Source reportedE1 |
| Entity status | Public listing published | Source reportedE1 |
| Published fact | US | Source reportedE1 |
Evidence
8 evidence records| Ref | Source | Authority | Source date | Retrieved | Rights | Cited by |
|---|---|---|---|---|---|---|
| E1 | Alpha canonical company public projectionCanonical identity | Open web | Not recorded | Rights not recorded, link only | 4 claims | |
| E2 | SEC DEF 14A 0001823239-26-000014SEC def 14a | Authoritative, regulatory filing | Rights not recorded, link only | 7 claims | ||
| E3 | DEF 14A mrvi-2026proxystatement.htmSEC proxy | Authoritative, regulatory filing | Rights not recorded, link only | 6 claims | ||
| E4 | MRVI executive roster sourceSEC filing | Authority not assessed | Rights not recorded, link only | 1 claim | ||
| E5 | MRVI executive roster sourceSEC filing | Authority not assessed | Rights not recorded, link only | 1 claim | ||
| E6 | MRVI executive roster sourceSEC filing | Authority not assessed | Rights not recorded, link only | 1 claim | ||
| E7 | MRVI executive roster sourceSEC filing | Authority not assessed | Rights not recorded, link only | 1 claim | ||
| E8 | AUDIT COMMITTEEgovernance_people_committees. SEC proxy | Authoritative, regulatory filing | Not recorded | Not recorded | Rights not recorded, link only | 10 claims |
No evidence record is pinned or signed yet.
Not yet in this record
These parts of a company record have no published claims yet. That is a coverage state, not a finding about the company. 1 further claim is under review.
- Control and voting
- Governance
- Risk
- AI oversight
- Legal
- Compensation
Index memberships
No current membership is published in Alpha's tracked index universe.
This is not evidence that the company is absent from every market index.
As of 21 Nov 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
Coverage states the record reports (12)
- Corporate structure
- Not reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- Ownership
- Not reviewed. Ownership and voting power determine who can influence the board.
- Financials
- Not reviewed. Governance-relevant financial context frames capital and audit decisions.
- Compensation
- Not reviewed. Pay design shows how incentives are governed.
- Governance
- Not reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governance
- Not reviewed. Meeting and vote records show shareholder dissent and support.
- Audit
- Not reviewed. Auditor, controls and restatements show assurance over reporting.
- Legal
- Not reviewed. Material legal and regulatory matters show enforcement exposure.
- Risk
- Not reviewed. Risk ownership links the board, committees, executives and controls.
- Cyber
- Not reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governance
- Not reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets external
- Not reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
Limits of this record (5)
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
History
Version public-1Published .
- Director appointed. John DeFord seat on MARAVAI LIFESCIENCES HOLDINGS, INC., effective 2023.Effective . Recorded .
- Director appointed. Constantine Mihas seat on MARAVAI LIFESCIENCES HOLDINGS, INC., effective 2020.Effective . Recorded .
- Director appointed. Gregory T. Lucier seat on MARAVAI LIFESCIENCES HOLDINGS, INC., effective 2020.Effective . Recorded .
- Director appointed. Luke Marker seat on MARAVAI LIFESCIENCES HOLDINGS, INC., effective 2020.Effective . Recorded .
- Director appointed. Sean Cunningham seat on MARAVAI LIFESCIENCES HOLDINGS, INC., effective 2020.Effective . Recorded .
- Director appointed. Susannah Gray seat on MARAVAI LIFESCIENCES HOLDINGS, INC., effective 2020.Effective . Recorded .
About this record
- Alpha ID
- alpha:company:ef418bb0-640d-4af9-bc29-e6a509f40fba
- Version
- public-1:ro-d751713988987e9331980363e24189ce
- Identity
- Not claimed
- Evidence
- Source reported
- Evaluation
- Not assessed
- Monitoring
- Not monitored yet
- Authority
- Not published
- Freshness
- Current
- Integrity
- Not signed yet
- Basis
- Published company record built from public sources
- Never published
- Private company data: deployments, authority grants, TrustChecks, receipts, telemetry
The company can claim this record and correct or dispute any claim. Corrections are versioned and the original stays in history. A company's own statements are shown as its own and never replace the cited evidence.

